This is so important for the company! So much is tied to this approval. Revenue from cannepil being the first. Imports can now begin through HL pharma to Australia. The European market opens up possibilities for sales.
Secondary is the production of new products for different conditions.
A lot of angst and impatience on these forums. Hopefully those with patience will now be rewarded. I expect a fairly consistent pipeline of announcements from here with solid share price gains from here. Good luck!
Add to My Watchlist
What is My Watchlist?
